In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...
Millions of people in the United States have type 2 diabetes and/or obesity. Many of the drugs that treat these often cause people to lose muscle mass. Muscle mass loss can cause a loss of strength ...
Early trial data suggest RNA therapies SRP-1001 and SRP-1003 reach muscle and show biomarker activity in muscular dystrophy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results